2020年第2届AACR国际会议——恶性淋巴瘤研究进展：最大化临床应用的基础转化连接

2020年第2届AACR国际会议：恶性淋巴瘤研究进展——最大化临床应用的基础转化连接/虚拟会议将于2020年8月17日至19日举行，会议由美国癌症研究协会(AACR)与国际恶性淋巴瘤国际会议(ICML)合作组织。会议将为基础科学家、转化研究人员、临床研究人员、血液学家、放射治疗师、儿科肿瘤学家、病理学家、计算和系统生物学家交流讨论集思广义提供一个活跃的国际性论坛，以了解淋巴瘤领域研究的最新进展。

Join us for the Second AACR International Meeting: Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application, being held in cooperation with the International Conference on Malignant Lymphoma (ICML). This must-attend program will consist of a series of bench-to-bedside debates on critical questions and unmet needs in the lymphoma field, followed by extended, interactive panel discussions. This will provide a dynamic, international forum for discussion and brainstorming among basic scientists, translational researchers, clinical investigators, hematologists, radiotherapists, pediatric oncologists, pathologists, computational and systems biologists, and patient advocates about how recent advances and emerging areas of lymphoma research hold enormous potential for transforming clinical care.

重要日期：
Abstract Submission Deadline: Thursday, June 30, 2020, 11:59 p.m. ET

注册费：-REGISTRATION RATES

Attendee registration includes admission to all sessions from August 17-19, 2020 and streaming access after the virtual meeting. All fees are listed in U.S. Dollars (USD) and are nonrefundable. 

*Please update your myAACR profile to ensure the correct registration rate populates based on your country’s World Bank income level.

会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。